| Name | | |
| Last NAV | 56.56 | 87.39 |
| Date of Valuation | 2025/11/21 | 2025/11/21 |
| Sharpe Ratio | N/A | -0.09 |
| 3-Year Risk Return Ratio | 1.10 | 1.50 |
| Cumulative Performance (%) |
| +8.92% | +7.80% |
| +33.08% | +36.55% |
| +57.15% | +65.07% |
| +44.10% | +125.70% |
| +17.29% | +6.46% |
| -17.36% | -10.59% |
| +33.53% | +34.55% |
| +465.60% | N/A |
| Calendar Year Performance (%) |
| +17.29% | +6.46% |
| -12.51% | -17.00% |
| -17.36% | -10.59% |
| +27.52% | +28.38% |
| +33.53% | +34.55% |
| 3-Year Annualised Volatility | 18.00% | 26.83% |
| Funds House | Franklin Templeton Investments (Asia) Ltd | BlackRock Asset Management North Asia Limited |
| Portfolio Manager | Evan McCulloch & Wendy Lam & Akiva Felt | Evy Hambro & Tom Holl |
| Funds Type | Equity Funds | Equity Funds |
| Funds Size | USD 1590000000 | USD 4468870000 |
| Base Currency | USD | USD |
| Sector | Biotechnology | Gold & Precious Metals |
| Geographic Allocation | US | Global |
| Top Holdings |
| AMGEN INC (8.16%) | AGNICO EAGLE MINES LTD (ONTARIO) (8.32%) |
| REGENERON PHARMACEUTICALS INC (7.13%) | BARRICK GOLD CORP (8.19%) |
| VERTEX PHARMACEUTICALS INC (5.83%) | NEWMONT CORPORATION (6.86%) |
| INSMED INC (3.82%) | KINROSS GOLD CORP (6.17%) |
| GILEAD SCIENCES INC (3.69%) | NORTHERN STAR RESOURCES LTD (4.99%) |
| ASTRAZENECA PLC (2.92%) | ALAMOS GOLD INC (PRE-REINCORPORATION) (4.76%) |
| INTRA-CELLULAR THERAPIES INC (2.84%) | SPROTT PHYSICAL SILVER TRUST (4.13%) |
| BIOGEN INC (2.74%) | WHEATON PRECIOUS METALS CORP (4.06%) |
| MERUS NV (2.73%) | LUNDIN GOLD INC (3.86%) |
| ARGENX SE (2.68%) | ENDEAVOUR MINING PLC (5.43%) |
| Minimum Initial Investment | USD 1000 | N/A |
| Initial Sales Fee | Class A: Up to 5.00%. Class B: Nil | Class A Shares: up to 5% of the price of shares.Class C Shares: Nil |
| Switching Fee | Class A: 1.00%. Class B: Nil | Nil(A 2% charge on redemptions/conversions may be levied where excessive trading by a shareholder is suspected.), except a delayed Initial Charge of up to 5% of the price of Class A Shares may be payable upon switching newly acquired Shares in a Reserve Fund into this Fund. |
| Maintenance Fee | Custodian fee Class A: Up to 0.14% ( As the investment objectives and policies of this fund provide for investments in equity securities of issuers in developing countries, there may be higher possible custodian annual fees for this fund.). Custodian fee Class B: Up to 0.14%( As the investment objectives and policies of this fund provide for investments in equity securities of issuers in developing countries, there may be higher possible custodian annual fees for this fund.). Maintenance charge Class A: Up to 0.50%. Maintenance charge Class B: Up to 0.75%. Servicing charge Class A: Nil. Servicing charge Class B: 1.06%. Registrar and Transfer, Corporate, Domiciliary and Administrative Agent fee + Additional fixed amount of USD per Shareholder account at the relevant Class level Class A: Up to 0.2175%, Up to USD 30 per annum. Registrar and Transfer, Corporate, Domiciliary and Administrative Agent fee + Additional fixed amount of USD per Shareholder account at the relevant Class level Class B: Up to 0.2175%, Up to USD 30 per annum. | Custodian Fees Safekeeping fees: 0.005% to 0.441%.Custodian Fees Transactional fees: US$8.8 to US$196 per transaction.Performance Fee : Nil.Administration Fee : Up to 0.25%(May be increased to a combined 2.25% maximum upon giving three months’ prior notice to shareholders.).Distribution Fee Class A Shares: Nil.Distribution Fee Class C Shares: 1.25%. |
| Redemption Fee | Class A: Nil. Class B: Up to 4.00% | Nil.(A 2% charge on redemptions/conversions may be levied where excessive trading by a shareholder is suspected.) |
| Launch Date | 2000/04/03 | 1994/12/30 |
| End of Financial Year | 30/06 | 31/08 |
| Country of Registry | Luxembourg | Luxembourg |
| Other Relevant Information | | |
| |